Molecules identified to mediate acetylation in HD include N-terminal actyltransferase (NAT) [65], Creb binding protein (CBP) [79] and Histone deacetylase 1 (HDAC1) [79,113] and may all be potential therapeutic targets to modulate HTT acetylation. This evidence concerns the gene CREBBP and Huntington disease.